Terms: = Ovarian cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Diagnosis
40 results:
1. FBXO28 promotes cell proliferation, migration and invasion via upregulation of the TGF-beta1/SMAD2/3 signaling pathway in ovarian cancer.
Song G; Sun Z; Chu M; Zhang Z; Chen J; Wang Z; Zhu X
BMC Cancer; 2024 Jan; 24(1):122. PubMed ID: 38267923
[TBL] [Abstract] [Full Text] [Related]
2. The relationship of lifetime history of depression on the ovarian tumor immune microenvironment.
Hathaway CA; Townsend MK; Conejo-Garcia JR; Fridley BL; Moran Segura C; Nguyen JV; Armaiz-Pena GN; Sasamoto N; Saeed-Vafa D; Terry KL; Kubzansky LD; Tworoger SS
Brain Behav Immun; 2023 Nov; 114():52-60. PubMed ID: 37557966
[TBL] [Abstract] [Full Text] [Related]
3. Metastasis from follicular lymphoma to an ovarian mature teratoma: a case report of tumor-to-tumor metastasis.
Sato Y; Yano M; Eto S; Takano K; Nasu K
J Ovarian Res; 2023 May; 16(1):106. PubMed ID: 37254134
[TBL] [Abstract] [Full Text] [Related]
4. Novel therapeutics in low-grade serous ovarian cancer.
Cobb L; Gershenson D
Int J Gynecol Cancer; 2023 Mar; 33(3):377-384. PubMed ID: 36878564
[TBL] [Abstract] [Full Text] [Related]
5. Impact of racial disparities on potential years of life lost due to gynecologic cancer in the United States: Trends from 1975 to 2017 based on SEER database.
Kaur A; Wang S; Kumar A
Gynecol Oncol; 2023 Mar; 170():266-272. PubMed ID: 36738485
[TBL] [Abstract] [Full Text] [Related]
6. The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors.
Wu Y; Du Z; Mou J; Qiu X; Chen J; Cai S; Ren D; Xiao F; Zhou G; Yuan C
Curr Med Chem; 2023; 30(20):2340-2353. PubMed ID: 35996244
[TBL] [Abstract] [Full Text] [Related]
7. Interobserver agreement between eight observers using IOTA simple rules and O-RADS lexicon descriptors for adnexal masses.
Antil N; Raghu PR; Shen L; Tiyarattanachai T; Chang EM; Ferguson CWK; Ho AA; Lutz AM; Mariano AJ; Morimoto LN; Kamaya A
Abdom Radiol (NY); 2022 Sep; 47(9):3318-3326. PubMed ID: 35763052
[TBL] [Abstract] [Full Text] [Related]
8. CCNB1, Negatively Regulated by miR-559, Promotes the Proliferation, Migration, and Invasion of ovarian Carcinoma Cells.
Yang X; Zhou S; Yang C; Cao C; He M; Zi S
Mol Biotechnol; 2022 Sep; 64(9):958-969. PubMed ID: 35262876
[TBL] [Abstract] [Full Text] [Related]
9. The mechanism of anticancer activity of the new synthesized compound - 6,7-Methylenedioxy-4-(2,4-dimethoxyphenyl)quinolin -2(1H)-one(12e) in human ovarian cancer cell lines.
Chan HC; Liao YH; Chang HW; Liu CH
Taiwan J Obstet Gynecol; 2021 Mar; 60(2):266-272. PubMed ID: 33678326
[TBL] [Abstract] [Full Text] [Related]
10. SR-B1 and CD10 combined immunoprofile for differential diagnosis of metastatic clear cell renal cell carcinoma and clear cell carcinoma of the ovary.
Jiang T; Diao X; Ding M; Niu X; Wang C; Qi Y; Jia W; Pang L; Hu W; Zou H; Li F
J Mol Histol; 2021 Jun; 52(3):539-544. PubMed ID: 33608777
[TBL] [Abstract] [Full Text] [Related]
11. Circular RNA S-7 promotes ovarian cancer EMT via sponging miR-641 to up-regulate ZEB1 and MDM2.
Zhang F; Xu Y; Ye W; Jiang J; Wu C
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667627
[TBL] [Abstract] [Full Text] [Related]
12. The effectiveness of anticancer traditional Korean medicine treatment on the survival in patients with lung, breast, gastric, colorectal, hepatic, uterine, or ovarian cancer: A prospective cohort study protocol.
Bae K; Kim E; Choi JJ; Kim MK; Yoo HS
Medicine (Baltimore); 2018 Oct; 97(41):e12444. PubMed ID: 30313034
[TBL] [Abstract] [Full Text] [Related]
13. Subclinical thiamine deficiency identified by preoperative evaluation in an ovarian cancer patient: diagnosis and the need for preoperative thiamine measurement.
Onishi H; Ishida M; Uchida N; Shintani D; Nishikawa T; Hasegawa K; Fujiwara K; Akechi T
Palliat Support Care; 2019 Oct; 17(5):609-610. PubMed ID: 30168403
[TBL] [Abstract] [Full Text] [Related]
14. Deregulation of the spindle assembly checkpoint is associated with paclitaxel resistance in ovarian cancer.
Chong T; Sarac A; Yao CQ; Liao L; Lyttle N; Boutros PC; Bartlett JMS; Spears M
J Ovarian Res; 2018 Apr; 11(1):27. PubMed ID: 29618387
[TBL] [Abstract] [Full Text] [Related]
15. Current treatment of double hit and double expressor lymphoma.
Reagan PM; Davies A
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):295-297. PubMed ID: 29222269
[TBL] [Abstract] [Full Text] [Related]
16. Tumor-Infiltrated Lymphocytes, Macrophages, and Dendritic Cells in Endometrioid Adenocarcinoma of Corpus Uteri as Potential Prognostic Factors: An Immunohistochemical Study.
Zinovkin D; Pranjol MZ
Int J Gynecol Cancer; 2016 Sep; 26(7):1207-12. PubMed ID: 27465886
[TBL] [Abstract] [Full Text] [Related]
17. Intravascular Large B-Cell Lymphoma Coexisting with an ovarian Carcinoma.
Uchiyama T; Nakamine H; Morita K; Itami H; Nakai T; Takano M; Takeda M; Hatakeyama K; Takahama J; Tanase Y; Kobayashi H; Ohbayashi C
J Clin Exp Hematop; 2016; 56(1):59-63. PubMed ID: 27334860
[TBL] [Abstract] [Full Text] [Related]
18. Diagnoses and Management of Drug Hypersensitivity and Anaphylaxis in cancer and Chronic Inflammatory Diseases: Reactions to Taxanes and Monoclonal Antibodies.
Bonamichi-Santos R; Castells M
Clin Rev Allergy Immunol; 2018 Jun; 54(3):375-385. PubMed ID: 27277133
[TBL] [Abstract] [Full Text] [Related]
19. ovarian Metastasis of a Thymoma: Report of a Case and Literature Review.
Martín-Hernández R; Villanueva MM; Sánchez MN; López EC
Int J Gynecol Pathol; 2015 Jul; 34(4):374-8. PubMed ID: 26061071
[TBL] [Abstract] [Full Text] [Related]
20. [Bilateral ovarian Burkitt's lymphoma. A case presentation].
Briseño-Hernández AA; Quezada-López DR; Castañeda-Chávez A; Dassaejv Macías-Amezcua M; Pintor-Belmontes JC
Cir Cir; 2014; 82(2):212-8. PubMed ID: 25312323
[TBL] [Abstract] [Full Text] [Related]
[Next]
